SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,891 | +16.3% | 50,689 | +55.8% | 0.00% | – |
| Q2 2023 | $151,256 | -90.1% | 32,528 | -90.2% | 0.00% | – |
| Q1 2023 | $1,528,148 | +51.2% | 330,768 | +164.4% | 0.00% | – |
| Q4 2022 | $1,010,824 | -39.7% | 125,102 | -58.6% | 0.00% | – |
| Q3 2022 | $1,676,000 | -50.4% | 302,092 | -53.4% | 0.00% | -100.0% |
| Q2 2022 | $3,376,000 | +14.8% | 647,999 | +81.1% | 0.00% | 0.0% |
| Q1 2022 | $2,942,000 | -66.9% | 357,845 | -40.0% | 0.00% | -50.0% |
| Q4 2021 | $8,880,000 | -29.8% | 596,770 | -10.9% | 0.00% | -33.3% |
| Q3 2021 | $12,650,000 | -12.0% | 669,643 | -13.4% | 0.00% | 0.0% |
| Q2 2021 | $14,370,000 | -37.5% | 772,994 | -23.5% | 0.00% | -40.0% |
| Q1 2021 | $23,002,000 | -18.1% | 1,010,620 | -21.8% | 0.01% | -28.6% |
| Q4 2020 | $28,071,000 | +128.9% | 1,293,004 | +6.0% | 0.01% | +133.3% |
| Q3 2020 | $12,262,000 | +24.3% | 1,220,125 | -4.0% | 0.00% | -25.0% |
| Q2 2020 | $9,867,000 | -37.6% | 1,271,523 | -17.9% | 0.00% | -42.9% |
| Q1 2020 | $15,803,000 | -16.9% | 1,549,354 | -10.4% | 0.01% | -12.5% |
| Q4 2019 | $19,019,000 | +21.0% | 1,728,976 | -0.0% | 0.01% | +14.3% |
| Q3 2019 | $15,724,000 | -20.1% | 1,729,804 | +0.1% | 0.01% | -22.2% |
| Q2 2019 | $19,669,000 | -0.1% | 1,728,345 | -0.0% | 0.01% | -10.0% |
| Q1 2019 | $19,696,000 | +26.3% | 1,729,203 | +0.0% | 0.01% | +11.1% |
| Q4 2018 | $15,596,000 | -40.5% | 1,729,043 | -1.1% | 0.01% | -25.0% |
| Q3 2018 | $26,226,000 | – | 1,748,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |